PharmaBlock Sciences Nanjing Inc
SZSE:300725

Watchlist Manager
PharmaBlock Sciences Nanjing Inc Logo
PharmaBlock Sciences Nanjing Inc
SZSE:300725
Watchlist
Price: 34.39 CNY -5.39% Market Closed
Market Cap: 6.8B CNY
Have any thoughts about
PharmaBlock Sciences Nanjing Inc?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

35.2
Current
46.5
Median
13.3
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
35.2
=
Enterprise Value
6.8B CNY
/
EBITDA
194m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
16.5
2-Years Forward
EV/EBITDA
14.8
3-Years Forward
EV/EBITDA
13.1

See Also

Discover More